LIMNW
Liminatus Pharma, Inc. Warrants
NASDAQ · Healthcare · Biotechnology · US
$0.06
+0.00%Leverage
- Debt / equity
- 4.80x
- Net debt / equity
- -5.24x
- Debt / assets
- 0.42x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.13x
Liquidity & coverage
- Current ratio
- 1.12x
- Quick ratio
- 1.12x
- Cash ratio
- 0.99x
- Interest coverage
- -53.78x
- EBITDA / interest
- -164.54x
- Working capital
- $352.0K
Cash & dividend
- FCF / debt
- -2.76x
- Cash flow / debt
- -2.75x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026